IgG4-related disease

SAN FRANCISCO, Calif., CAMBRIDGE, Mass., & SUZHOU, China, July 14, 2026 Innovent Biologics and Spero Therapeutics have entered into...

Paris, March 2, 2026 Sanofi announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug...

The FDA has approved updated COVID-19 vaccines from Pfizer/BioNTech, Moderna, and Novavax for the 2025-2026 season, targeting high-risk groups....

The FDA approved updated COVID-19 vaccines from Pfizer/BioNTech, Moderna, and Novavax while ending broad Emergency Use Authorization. Eligibility is...

AbbVie (NYSE: ABBV) has announced a definitive agreement to acquire Gilgamesh Pharmaceuticals’ lead investigational candidate bretisilocin (GM-2505), a next-generation...

PharmaTher Holdings Ltd. announced FDA approval of KETARx™, its ketamine product for anesthesia and sedation, marking a significant milestone...

Terumo Corporation is acquiring UK-based OrganOx Limited for approximately USD 1.5 billion, enhancing its entry into the organ transplantation...

EVERSANA and Waltz Health announced a merger today to form a unified healthcare platform designed to redefine pharmaceutical commercialization...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced today that it will present new clinical data on its investigational therapy...

Shanghai, China, August 26, 2025 – In a landmark advancement, CorrectSequence Therapeutics Co., Ltd. (Correctseq) has announced the first...